Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05396326 | A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer | unknown | Phase 1 | 20 | Shanghai Zhongshan HospitalOTHER | 0 | May 31, 2022 | clinicaltrials |
| NCT05346874 | Neoadjuvant TACiE in Locally Advanced Gastric Cancer | unknown | Phase 2 | 37 | Shanghai Zhongshan HospitalOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT05390684 |
| Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy.(PROFUGO) |
| unknown |
| — |
| 800 |
| Hospital Universitario La FeOTHER |
| 1 |
| May 25, 2022 |
| clinicaltrials |
| NCT05361161 | Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC) | unknown | Phase 2 | 60 | Gang WuOTHER | 0 | May 24, 2022 | clinicaltrials |
| NCT05385900 | Immune Combined Targeted and Chemotherapy in Perioperative Treatment of Locally Advanced Gastric Cancer(ICTCPTLAGC) | unknown | N/A | 57 | Xijing HospitalOTHER | 0 | May 23, 2022 | clinicaltrials |
| NCT05238584 | Total Versus Partial Omentectomy in the Treatment of Gastric Cancer(TOPO) | unknown | N/A | 300 | University of DebrecenOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT02781285 | Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score(ESCOTCMAGCPS) | unknown | — | 1,500 | Shanghai University of Traditional Chinese MedicineOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT02562963 | Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 120 | Minghui ZhangOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT05246982 | HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer | unknown | Phase 2 | 40 | Shanghai Henlius BiotechINDUSTRY | 1 | May 2, 2022 | clinicaltrials |
| NCT05027347 | Detection of Plasma Circulating Tumor DNA in Gastric Cancer | unknown | — | 200 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05061082 | Genomic Evolution of Metastasis in Gastric Cancer | unknown | — | 20 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05351398 | The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Gastric Cancer | unknown | — | 54 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05342389 | Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer | unknown | Phase 2 | 68 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT04675866 | Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer | unknown | N/A | 46 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 15, 2022 | clinicaltrials |
| NCT05319392 | Transcriptomic Signatures in Gastric Adenocarcinoma(GAC) | unknown | — | 48 | Sanjay Gandhi Postgraduate Institute of Medical SciencesOTHER_GOV | 1 | Apr 15, 2022 | clinicaltrials |
| NCT05315830 | A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric | unknown | Phase 1 | 10 | The First Affiliated Hospital of Bengbu Medical UniversityOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03958019 | Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer(RESTORE II) | unknown | N/A | 120 | University of Dublin, Trinity CollegeOTHER | 1 | Apr 13, 2022 | clinicaltrials |
| NCT05313906 | RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer | unknown | Phase 2 | 40 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 6, 2022 | clinicaltrials |
| NCT05311189 | Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer | unknown | Phase 2 | 40 | Shanghai Zhongshan HospitalOTHER | 0 | Apr 5, 2022 | clinicaltrials |
| NCT05301465 | Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab. | unknown | — | 50 | University of PisaOTHER | 1 | Mar 29, 2022 | clinicaltrials |
| NCT04801459 | Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y Reconstruction | unknown | N/A | 148 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT05287672 | Retrospective Study of Effect of Adjuvant Chemoradiation of Gastric Carcinoma on Local Control and Survival | unknown | — | 30 | Assiut UniversityOTHER | 0 | Mar 18, 2022 | clinicaltrials |
| NCT04119622 | Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer | unknown | Phase 2 | 30 | Aiping ZhouUNKNOWN | 1 | Mar 11, 2022 | clinicaltrials |
| NCT04825470 | Liver Transplantation for Unresectable GIST Liver Metastases(TRANSGIST) | unknown | N/A | 50 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05275062 | Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma | unknown | Early Phase 1 | 6 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05270889 | Study to Evaluate the Safety and Efficacy of Tislelizumab in Combination With Zanidatamab as a 2nd Line in HER2-Positive Advanced Gastric Cancer in K-Umbrella Trial | unknown | Phase 2 | 50 | Yonsei UniversityOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT05141747 | A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer. | unknown | Phase 2 | 60 | Shanghai Miracogen Inc.INDUSTRY | 1 | Feb 23, 2022 | clinicaltrials |
| NCT04808466 | Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy(WUHIPEC01) | unknown | Phase 2 | 231 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Feb 21, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT02970539 | Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers | unknown | Phase 1 | 36 | Athenex, Inc.INDUSTRY | 2 | Feb 16, 2022 | clinicaltrials |
| NCT05241899 | A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer | unknown | Phase 2 | 56 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT01889303 | Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer | unknown | Phase 2 | 100 | Wuhan UniversityOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT05228743 | Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer | unknown | N/A | 180 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT05227378 | Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer | unknown | N/A | 36 | Shen LinOTHER | 1 | Feb 7, 2022 | clinicaltrials |
| NCT05221775 | Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients | unknown | Phase 1 | 18 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 3, 2022 | clinicaltrials |
| NCT03939962 | Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma | unknown | Phase 2 | 60 | Henan Cancer HospitalOTHER_GOV | 1 | Jan 26, 2022 | clinicaltrials |
| NCT05208372 | Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer(CTC_ctDNA) | unknown | — | 200 | First Hospital of China Medical UniversityOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT05205187 | Gut Microbiota and Metabonomics(MBS) | unknown | — | 450 | First Hospital of China Medical UniversityOTHER | 1 | Jan 25, 2022 | clinicaltrials |
| NCT04062058 | A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer | unknown | Phase 2 | 82 | Jing Jin, M.D.UNKNOWN | 1 | Jan 24, 2022 | clinicaltrials |
| NCT05203549 | Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric Cancer | unknown | — | 250 | D1 Medical Technology (Shanghai) Co., Ltd, ChinaINDUSTRY | 1 | Jan 24, 2022 | clinicaltrials |
| NCT05204173 | Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis | unknown | Phase 2 | 30 | Ruijin HospitalOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT05198856 | Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC | unknown | Phase 1 / Phase 2 | 106 | Qilu Hospital of Shandong UniversityOTHER | 0 | Jan 20, 2022 | clinicaltrials |
| NCT04782791 | Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer | unknown | Phase 2 | 30 | Chinese PLA General HospitalOTHER | 0 | Jan 11, 2022 | clinicaltrials |
| NCT05184946 | Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma | unknown | Phase 2 | 72 | The Second Affiliated Hospital of Shandong First Medical UniversityOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT03801668 | Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma | unknown | Phase 3 | 294 | Huazhong University of Science and TechnologyOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT04593134 | Effectiveness of Exercise Program in Improving Quality of Life in Patients With Gastric Cancer Undergoing Gastrectomy | unknown | N/A | 160 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 21, 2021 | clinicaltrials |
| NCT05165602 | Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System | unknown | — | 30 | Peking UniversityOTHER | 1 | Dec 21, 2021 | clinicaltrials |
Data updated 23 days agoSource updated May 31, 2022source: clinicaltrials